Type IV Collagen in Human Colorectal Liver Metastases—Cellular Origin and a Circulating Biomarker

Circulating type IV collagen (cCOL IV) is a potential biomarker for patients with colorectal liver metastases (CLM) who present with elevated levels of COL IV in both CLM tissue and circulation. This study aimed to establish the cellular origin of elevated levels of COL IV and analyze circulating CO...

Full description

Bibliographic Details
Main Authors: Moa Lindgren, Gunilla Rask, Josefin Jonsson, Anette Berglund, Christina Lundin, Pär Jonsson, Ingrid Ljuslinder, Hanna Nyström
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/14/3396
_version_ 1797407095530717184
author Moa Lindgren
Gunilla Rask
Josefin Jonsson
Anette Berglund
Christina Lundin
Pär Jonsson
Ingrid Ljuslinder
Hanna Nyström
author_facet Moa Lindgren
Gunilla Rask
Josefin Jonsson
Anette Berglund
Christina Lundin
Pär Jonsson
Ingrid Ljuslinder
Hanna Nyström
author_sort Moa Lindgren
collection DOAJ
description Circulating type IV collagen (cCOL IV) is a potential biomarker for patients with colorectal liver metastases (CLM) who present with elevated levels of COL IV in both CLM tissue and circulation. This study aimed to establish the cellular origin of elevated levels of COL IV and analyze circulating COL IV in CLM patients. The cellular source was established through in situ hybridization, immunohistochemical staining, and morphological evaluation. Cellular expression in vitro was assessed by immunofluorescence. Tissue expression of COL IV-degrading matrix metalloproteinases (MMPs)-2, -7, -9, and -13 was studied with immunohistochemical staining. Plasma levels of COL IV in CLM patients and healthy controls were analyzed with ELISA. This study shows that cancer-associated fibroblasts (CAFs) express COL IV in the stroma of CLM and that COL IV is expressed in vitro by fibroblasts but not by tumor cells. MMP-2, -7, -9, and -13 are expressed in CLM tissue, mainly by hepatocytes and immune cells, and circulating COL IV is significantly elevated in CLM patients compared with healthy controls. Our study shows that stromal cells, not tumor cells, produce COL IV in CLM, and that circulating COL IV is elevated in patients with CLM.
first_indexed 2024-03-09T03:36:18Z
format Article
id doaj.art-400937262afb40f09be45a490af0cbeb
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T03:36:18Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-400937262afb40f09be45a490af0cbeb2023-12-03T14:47:26ZengMDPI AGCancers2072-66942022-07-011414339610.3390/cancers14143396Type IV Collagen in Human Colorectal Liver Metastases—Cellular Origin and a Circulating BiomarkerMoa Lindgren0Gunilla Rask1Josefin Jonsson2Anette Berglund3Christina Lundin4Pär Jonsson5Ingrid Ljuslinder6Hanna Nyström7Department of Surgical and Perioperative Sciences/Surgery, Umeå University, SE-901 85 Umeå, SwedenDepartment of Surgical and Perioperative Sciences/Surgery, Umeå University, SE-901 85 Umeå, SwedenDepartment of Surgical and Perioperative Sciences/Surgery, Umeå University, SE-901 85 Umeå, SwedenDepartment of Surgical and Perioperative Sciences/Surgery, Umeå University, SE-901 85 Umeå, SwedenDepartment of Surgical and Perioperative Sciences/Surgery, Umeå University, SE-901 85 Umeå, SwedenDepartment of Chemistry, Umeå University, SE-907 36 Umeå, SwedenDepartment of Radiation Sciences/Oncology, Umeå University, SE-901 87 Umeå, SwedenDepartment of Surgical and Perioperative Sciences/Surgery, Umeå University, SE-901 85 Umeå, SwedenCirculating type IV collagen (cCOL IV) is a potential biomarker for patients with colorectal liver metastases (CLM) who present with elevated levels of COL IV in both CLM tissue and circulation. This study aimed to establish the cellular origin of elevated levels of COL IV and analyze circulating COL IV in CLM patients. The cellular source was established through in situ hybridization, immunohistochemical staining, and morphological evaluation. Cellular expression in vitro was assessed by immunofluorescence. Tissue expression of COL IV-degrading matrix metalloproteinases (MMPs)-2, -7, -9, and -13 was studied with immunohistochemical staining. Plasma levels of COL IV in CLM patients and healthy controls were analyzed with ELISA. This study shows that cancer-associated fibroblasts (CAFs) express COL IV in the stroma of CLM and that COL IV is expressed in vitro by fibroblasts but not by tumor cells. MMP-2, -7, -9, and -13 are expressed in CLM tissue, mainly by hepatocytes and immune cells, and circulating COL IV is significantly elevated in CLM patients compared with healthy controls. Our study shows that stromal cells, not tumor cells, produce COL IV in CLM, and that circulating COL IV is elevated in patients with CLM.https://www.mdpi.com/2072-6694/14/14/3396type IV collagenCOL IVcolorectal cancerliver metastasescirculating biomarkerstumor stroma
spellingShingle Moa Lindgren
Gunilla Rask
Josefin Jonsson
Anette Berglund
Christina Lundin
Pär Jonsson
Ingrid Ljuslinder
Hanna Nyström
Type IV Collagen in Human Colorectal Liver Metastases—Cellular Origin and a Circulating Biomarker
Cancers
type IV collagen
COL IV
colorectal cancer
liver metastases
circulating biomarkers
tumor stroma
title Type IV Collagen in Human Colorectal Liver Metastases—Cellular Origin and a Circulating Biomarker
title_full Type IV Collagen in Human Colorectal Liver Metastases—Cellular Origin and a Circulating Biomarker
title_fullStr Type IV Collagen in Human Colorectal Liver Metastases—Cellular Origin and a Circulating Biomarker
title_full_unstemmed Type IV Collagen in Human Colorectal Liver Metastases—Cellular Origin and a Circulating Biomarker
title_short Type IV Collagen in Human Colorectal Liver Metastases—Cellular Origin and a Circulating Biomarker
title_sort type iv collagen in human colorectal liver metastases cellular origin and a circulating biomarker
topic type IV collagen
COL IV
colorectal cancer
liver metastases
circulating biomarkers
tumor stroma
url https://www.mdpi.com/2072-6694/14/14/3396
work_keys_str_mv AT moalindgren typeivcollageninhumancolorectallivermetastasescellularoriginandacirculatingbiomarker
AT gunillarask typeivcollageninhumancolorectallivermetastasescellularoriginandacirculatingbiomarker
AT josefinjonsson typeivcollageninhumancolorectallivermetastasescellularoriginandacirculatingbiomarker
AT anetteberglund typeivcollageninhumancolorectallivermetastasescellularoriginandacirculatingbiomarker
AT christinalundin typeivcollageninhumancolorectallivermetastasescellularoriginandacirculatingbiomarker
AT parjonsson typeivcollageninhumancolorectallivermetastasescellularoriginandacirculatingbiomarker
AT ingridljuslinder typeivcollageninhumancolorectallivermetastasescellularoriginandacirculatingbiomarker
AT hannanystrom typeivcollageninhumancolorectallivermetastasescellularoriginandacirculatingbiomarker